Publicacións en colaboración con investigadores/as de University of Ottawa (19)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review

    The Journal of rheumatology, Vol. 50, Núm. 6, pp. 789-798

  3. The NIA-AA revised clinical criteria for Alzheimer's disease: are they too advanced?

    International Psychogeriatrics

2020

  1. Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study

    The Lancet Neurology, Vol. 19, Núm. 10, pp. 840-848

  2. MiR-219a-5p enriched extracellular vesicles induce OPC differentiation and EAE improvement more efficiently than liposomes and polymeric nanoparticles

    Pharmaceutics, Vol. 12, Núm. 2

  3. Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer

    Gut, Vol. 69, Núm. 8, pp. 1460-1471

2019

  1. Aging Disrupts Muscle Stem Cell Function by Impairing Matricellular WISP1 Secretion from Fibro-Adipogenic Progenitors

    Cell Stem Cell, Vol. 24, Núm. 3, pp. 433-446.e7

  2. Novel common genetic susceptibility loci for colorectal cancer

    Journal of the National Cancer Institute, Vol. 111, Núm. 2, pp. 146-157

2018

  1. Early human dispersals within the Americas

    Science (New York, N.Y.), Vol. 362, Núm. 6419

2017

  1. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

    Chest, Vol. 151, Núm. 3, pp. 564-571

2015

  1. Action of obestatin in skeletal muscle repair: Stem cell expansion, muscle growth, and microenvironment remodeling

    Molecular Therapy, Vol. 23, Núm. 6, pp. 1003-1021

  2. Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 6, pp. 963-969

2011

  1. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 3, pp. 404-413

  2. American college of rheumatology/European league against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

    Arthritis and Rheumatism, Vol. 63, Núm. 3, pp. 573-586

  3. Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: A EULAR initiative

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 6, pp. 935-942

2010

  1. COGENT (COlorectal cancer GENeTics): An international consortium to study the role of polymorphic variation on the risk of colorectal cancer

    British Journal of Cancer, Vol. 102, Núm. 2, pp. 447-454

2008

  1. Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients withd-heumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 10, pp. 1365-1373

  2. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 10, pp. 1360-1364

  3. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

    Arthritis Care and Research, Vol. 59, Núm. 10, pp. 1371-1377